Evidence map›Paper›PMID 24974178›Full record

ArticleAdvances in cancer research2014

Reactive oxygen species in normal and tumor stem cells.

Daohong Zhou, Lijian Shao, Douglas R Spitz

Abstract read
In one paragraph

Article in Advances in cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review.Cellular and molecular gastroenterology and hepatology · 2021
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Metabolomics of healthy hematopoietic stem cells and leukemic stem cells.Journal of clinical and translational research · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Injectable Dendritic Hydrogels Curable by High-Energy Visible Light for Cell Delivery in Bone Regeneration.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
  17. Review
  18. Review
  19. Review
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daohong ZhouDivision of Radiation Health, Department of Pharmaceutical Sciences, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. Electronic address: dzhou@uams.edu.
Lijian ShaoDivision of Radiation Health, Department of Pharmaceutical Sciences, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Douglas R SpitzFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA. Electronic address: douglas-spitz@uiowa.edu.

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Cancer Therapy-induced Long-term Bone Marrow InjuryR01CA122023 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2007 to 2018
$3.1M
Role of p38 MAPK in HSC Self-Renewal and Radiation-Induced Bone Marrow InjuryR01AI080421 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2008 to 2012
$1.8M
Enhancing Metabolic Oxidative Stress and Therapy Responses in Cancer Stem CellsR01CA182804 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2014 to 2018
$1.7M
MOLECULAR PATHOGENESIS OF RADIATION ENTEROPATHYR01CA071382 · NCI · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI HAUER-JENSEN, MARTIN · 1997 to 2005
$1.6M
The Use of 2-Deoxyglucose in Head and Neck Cancer TherapyR01CA133114 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2009 to 2013
$1.5M
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I TrialR21CA161182 · NCI · UNIVERSITY OF IOWA · PI BERG, DANIEL J, BUATTI, JOHN M · 2011 to 2012
$340k
NCI NIH HHS R01 CA071382NCI NIH HHS R01 CA122023NCI NIH HHS R01-CA122023NCI NIH HHS R01 CA133114NCI NIH HHS R01CA133114NCI NIH HHS R01 CA182804NCI NIH HHS R01CA182804NCI NIH HHS R21 CA161182NCI NIH HHS R21CA161182NIAID NIH HHS AI080421NIAID NIH HHS R01 AI080421NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Reactive oxygen species (ROS) play an important role in determining the fate of normal stem cells. Low levels of ROS are required for stem cells to maintain quiescence and self-renewal. Increases in ROS production cause stem cell proliferation/differentiation, senescence, and apoptosis in a dose-dependent manner, leading to their exhaustion. Therefore, the production of ROS in stem cells is tightly regulated to ensure that they have the ability to maintain tissue homeostasis and repair damaged tissues for the life span of an organism. In this chapter, we discuss how the production of ROS in normal stem cells is regulated by various intrinsic and extrinsic factors and how the fate of these cells is altered by the dysregulation of ROS production under various pathological conditions. In addition, the implications of the aberrant production of ROS by tumor stem cells for tumor progression and treatment are also discussed.

Indexed as

AnimalsAntioxidantsApoptosisCell DifferentiationCell ProliferationCellular SenescenceDose-Response Relationship, DrugEmbryonic Stem CellsHomeostasisHumansHypoxiaMiceMitochondriaNeoplasmsNeoplastic Stem CellsRadiation, IonizingAntioxidantsReactive Oxygen SpeciesAdult stem cellsApoptosisDifferentiationEmbryonic stem cellsHematopoietic stem cellsHypoxiaIonizing radiationReactive oxygen speciesSenescenceTumor stem cells

Identifiers

PMID24974178
PMCPMC4207279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.